Akash Patnaik

Akash Patnaik practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Akash Patnaik's NPI, 1750360962, was assigned on January 16, 2006. Akash Patnaik graduated from Pennsylvania State University College of Medicine in 2003. Akash Patnaik holds Illinois license 036139341.

Akash Patnaik's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Akash Patnaik's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Akash Patnaik is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Akash Patnaik to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Akash Patnaik practices. Vendor and product names are available with a free account.

Hematology and oncology is Akash Patnaik's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Akash Patnaik is licensed in Illinois.

CMS data shows 74 Medicare services from Akash Patnaik across 1 procedure code in 2024, all of them office visits, for 36 Medicare patients. Medicare paid $8,479 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Akash Patnaik in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Akash Patnaik's median patient age at 73, with 8% women.

In 2024, Akash Patnaik wrote 462 Medicare Part D claims for 44 patients. 66% of them were for generic drugs. CMS names the drug for 439 of them, across 6 drugs with 11 or more claims each, at $1,360,954 in total drug cost. In 2023, CMS named 524 claims across 5 drugs.

Akash Patnaik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Akash Patnaik as offering telehealth.

Dmand AI links 31 papers to Akash Patnaik, published from 2013 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasms and Androgen Antagonists. Akash Patnaik has published most often in Clin Cancer Res. Akash Patnaik's most frequent co-authors are Wassim Abida, MD, PhD, Alan Haruo Bryce, MD and Brian W. Labadie.

Dmand AI links Akash Patnaik to 3 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Endometrial Neoplasms, Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 142 general payments to Akash Patnaik from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Bristol-Myers Squibb Company paid the most, $23,126.

Akash Patnaik graduated from Pennsylvania State University College of Medicine in 2003.